iShares Global Healthcare ETF Rating $93.76 +0.44 (+0.47%) (As of 11/1/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares Global Healthcare ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IXJ Aggregate RatingModerate Buy2.74Holdings in IXJ have an aggregate rating of Moderate Buy based on 601 analyst ratings issued in the past year covering 34 companies (64.8% of the portfolio).IXJ Aggregate Price Target$106.4813.56% UpsideHigh Prediction$125.35Average Prediction$106.48Low Prediction$85.46Holdings in IXJ have an aggregate price target of $106.48 and a range of $85.46 to $125.35 covering 34 companies (64.8% of the portfolio).IXJ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Global Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 34 IXJ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.19%LLYEli Lilly and Company$818.93-1.3%4.9036 of 5 stars2.84$1,009.00 23.2%19Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision6.67%UNHUnitedHealth Group$567.56+0.5%4.8989 of 5 stars2.95$615.53 8.5%22Positive News4.78%JNJJohnson & Johnson$160.13+0.2%4.8841 of 5 stars2.54$175.93 9.9%13Short Interest ↓4.23%ABBVAbbVie$203.55-0.2%4.8493 of 5 stars2.84$201.00 -1.3%19Earnings ReportDividend IncreaseAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage3.50%MRKMerck & Co., Inc.$101.88-0.4%4.9993 of 5 stars2.88$129.93 27.5%17Earnings ReportAnalyst ForecastNews Coverage2.92%TMOThermo Fisher Scientific$557.92+2.1%4.964 of 5 stars2.86$649.33 16.4%22Insider Selling2.64%ABTAbbott Laboratories$118.60+4.6%4.8882 of 5 stars2.75$129.67 9.3%16Options VolumeNews CoverageGap Up2.35%ISRGIntuitive Surgical$506.34+0.5%4.841 of 5 stars2.68$513.74 1.5%19Insider SellingShort Interest ↓2.24%DHRDanaher$247.76+0.9%4.9188 of 5 stars2.74$287.16 15.9%19Analyst UpgradeShort Interest ↓2.19%AMGNAmgen$319.22-0.3%4.5959 of 5 stars2.50$333.50 4.5%24Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision2.10%PFEPfizer$28.09-0.7%4.9889 of 5 stars2.60$33.58 19.6%15Earnings ReportAnalyst UpgradeAnalyst Revision1.65%BSXBoston Scientific$83.62-0.5%4.8528 of 5 stars2.91$93.39 11.7%23Analyst Forecast1.61%SYKStryker$367.15+3.1%4.9514 of 5 stars2.80$393.65 7.2%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.58%VRTXVertex Pharmaceuticals$471.12-1.0%3.4466 of 5 stars2.48$492.50 4.5%29Upcoming EarningsAnalyst Forecast1.50%MDTMedtronic$90.07+0.9%4.7218 of 5 stars2.44$95.36 5.9%161.37%BMYBristol-Myers Squibb$54.32-2.6%4.5139 of 5 stars1.93$53.00 -2.4%14Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.37%GILDGilead Sciences$89.51+0.8%4.9348 of 5 stars2.65$86.85 -3.0%23Upcoming EarningsAnalyst Forecast1.33%REGNRegeneron Pharmaceuticals$843.60+0.6%4.8453 of 5 stars2.73$1,090.24 29.2%22Analyst ForecastAnalyst RevisionNews Coverage1.27%ELVElevance Health$414.01+2.0%4.95 of 5 stars2.81$551.07 33.1%16Positive NewsHigh Trading Volume1.19%CIThe Cigna Group$316.49+0.5%4.9965 of 5 stars3.00$392.29 23.9%15Earnings ReportAnalyst ForecastShort Interest ↓News Coverage1.11%ZTSZoetis$181.95+1.8%4.907 of 5 stars3.10$221.44 21.7%10Upcoming Earnings0.98%HCAHCA Healthcare$357.19-0.4%4.7188 of 5 stars2.85$379.11 6.1%20Dividend AnnouncementShort Interest ↑Analyst Revision0.95%CVSCVS Health$55.81-1.2%5 of 5 stars2.60$73.17 31.1%20Upcoming Earnings0.89%BDXBecton, Dickinson and Company$235.24+0.7%4.8544 of 5 stars3.00$282.63 20.1%8Upcoming Earnings0.84%MCKMcKesson$526.34+5.1%4.9605 of 5 stars2.75$610.86 16.1%16Upcoming EarningsDividend Announcement0.54%EWEdwards Lifesciences$67.54+0.8%4.6297 of 5 stars2.38$75.67 12.0%26Analyst DowngradeShort Interest ↓Analyst RevisionNews Coverage0.53%CORCencora$234.27+2.7%4.9695 of 5 stars2.70$259.44 10.7%10Upcoming EarningsShort Interest ↓Positive News0.53%GEHCGE HealthCare Technologies$86.95-0.5%4.0646 of 5 stars2.60$94.36 8.5%15Earnings ReportAnalyst Forecast0.52%IQVIQVIA$209.16+1.6%4.9021 of 5 stars2.84$261.24 24.9%19Analyst UpgradeShort Interest ↓News Coverage0.51%AAgilent Technologies$136.87+5.0%4.5796 of 5 stars2.50$144.36 5.5%14Positive NewsGap Up0.48%IDXXIDEXX Laboratories$417.28+2.5%4.803 of 5 stars2.78$574.13 37.6%9Earnings ReportNews CoverageHigh Trading Volume0.45%RMDResMed$244.28+0.7%4.5102 of 5 stars2.50$225.70 -7.6%12Gap Up0.42%CNCCentene$63.52+2.0%4.934 of 5 stars2.50$84.00 32.2%14Analyst Forecast0.41%HUMHumana$260.71+1.1%4.8993 of 5 stars2.20$315.48 21.0%25Earnings ReportAnalyst ForecastAnalyst Revision This page (NYSEARCA:IXJ) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Global Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Global Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
